Advertisement
Canada markets open in 1 hour 34 minutes

  • S&P/TSX

    21,871.96
    +64.59 (+0.30%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • DOW

    38,239.98
    +253.58 (+0.67%)
     

  • CAD/USD

    0.7297
    -0.0004 (-0.05%)
     

  • CRUDE OIL

    81.39
    -0.51 (-0.62%)
     

  • Bitcoin CAD

    90,555.32
    +196.56 (+0.22%)
     

  • CMC Crypto 200

    1,417.95
    +3.20 (+0.23%)
     

  • GOLD FUTURES

    2,315.90
    -30.50 (-1.30%)
     

  • RUSSELL 2000

    1,967.47
    +19.82 (+1.02%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,399.25
    +49.25 (+0.28%)
     

  • VOLATILITY

    16.62
    -0.32 (-1.89%)
     

  • FTSE

    8,047.60
    +23.73 (+0.30%)
     

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • CAD/EUR

    0.6832
    -0.0018 (-0.26%)
     

Today’s Research Reports on Trending Tickers: Akorn and Dermira

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / March 6, 2018 / U.S. markets rallied Monday, with the Dow breaking a streak of 4 consecutive losses, as concerns over a potential trade war eased. The Dow Jones Industrial Average spiked 1.37 percent to close at 24,874.76, while the S&P 500 Index jumped 1.1 percent to close at 2,720.94. The Nasdaq Composite Index increased to close at 7,330.70. The Dow and S&P 500 recorded losses of 3 percent and 2 percent, respectively, last week.

"I see today's rebound as more of a technical bounce. After two days of declines on big volume last week, stocks are bouncing back today on light volume. This suggests that the bears have backed off for now, allowing the market to recover a bit. We may also be seeing a bit of bargain hunting or short covering," said Colin Cieszynski, chief market strategist at SIA Wealth Management, according to MarketWatch.

RDI Initiates Coverage on:

Akorn, Inc.
https://rdinvesting.com/news/?ticker=AKRX

ADVERTISEMENT

Dermira, Inc.
https://rdinvesting.com/news/?ticker=DERM

Akorn's stock moved 5.48% lower Monday, to close the day at $17.93. The stock recorded a trading volume of 3,723,709 shares, which was above its three months average volume of 2,157,510 shares. In the last year, Akorn's shares have traded in a range of 16.79 - 34.00. The stock is currently trading 47.26% below its 52 week high. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $30.38 is below its 200-day moving average of $32.24. Shares of Akorn have fallen roughly 43.97 percent in the past month and are down 44.37 percent year-to-date.

Access RDI's Akorn, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AKRX

On Monday, shares of Dermira recorded a trading volume of 30,000,206 shares, which was above the three months average volume of 615,230 shares. The stock ended the day 65.86% lower at 8.59. The stock is currently trading 77.62% below its 52 week high with a 52 week trading range of 8.55 - 38.39. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $27.63 is greater than its 200-day moving average of $26.49. Shares of Dermira have fallen roughly 67.72 percent in the past month and are down 69.11 percent year-to-date.

Access RDI's Dermira, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=DERM

Our Actionable Research on Akorn, Inc. (NASDAQ:AKRX) and Dermira, Inc. (NASDAQ:DERM) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com